Janssen-Cilag Kft. clinical trials
A country office of Johnson & Johnson
The registry lists 1 studies whose lead sponsor is Janssen-Cilag Kft.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 28, 2026.
Registry sponsor names on this page
- Janssen-Cilag Kft.1 study
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Johnson & Johnson studies →
- A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical PracticeRecruitingNCT07746583
Sponsor listed in the registry: Janssen-Cilag Kft.